Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. (Q44221521)
Jump to navigation
Jump to search
scientific article published in December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. |
scientific article published in December 2002 |
Statements
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma (English)
Thieblemont C
Saad H
Roch N
Bouafia F
Arnaud P
Espinouse D
Salles G
Eljaafari-Corbin A
Du Manoir-Baumgarten C
1 December 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference